Hepatic encephalopathy following transjugular intrahepatic portosystemic shunt (TIPS): management with L-ornithine-L-aspartate and stent reduction

Metab Brain Dis. 2007 Mar;22(1):45-50. doi: 10.1007/s11011-006-9032-3. Epub 2006 Dec 14.

Abstract

Hepatic encephalopathy (HE) is a common problem after insertion of a trans-jugular intrahepatic portosystemic shunt (TIPS), which may be difficult to manage. We present a case of severe post-TIPS HE unresponsive to high doses of L-ornithine-L-aspartate (LOLA) despite reduction of venous ammonia levels in a dose-dependent fashion. Ultimately, high-grade HE was successfully treated by a reduction stent and the patient subsequently underwent successful liver transplantation.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Ammonia / blood
  • Dipeptides / administration & dosage*
  • Hepatic Encephalopathy / drug therapy*
  • Hepatic Encephalopathy / etiology
  • Humans
  • Liver Diseases, Alcoholic / surgery*
  • Liver Transplantation
  • Male
  • Portasystemic Shunt, Transjugular Intrahepatic*
  • Postoperative Complications
  • Stents*

Substances

  • Dipeptides
  • Ammonia
  • ornithylaspartate